# Ducommun Labarge Technologies – FDA Inspection, Jun 27, 2025

Source: https://www.keypedia.com/records/fda_inspections/ducommun-labarge-technologies/867c8c8c-4b26-486a-9a0a-885e3ca956ec
Source feed: FDA_Inspections

> FDA inspection 1274180 of Ducommun Labarge Technologies, June 27, 2025. Classification: No Action Indicated (NAI). 4 citations under 21 CFR part 820. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1274180
- Company Name: Ducommun Labarge Technologies
- Inspection Date: 2025-06-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: Minneapolis District Office
- Citation Count: 4

## Related Documents

- [FDA Inspection 1022305 - 2017-08-11](https://www.keypedia.com/records/fda_inspections/ducommun-labarge-technologies/8aaa74d9-1543-4fa9-a25d-12d99152898c)
- FDA Inspection 887596 - 2014-07-17

## Related Officers

- [Investigator](https://www.keypedia.com/people/shuana-h-xiong/45ee2b1d-fbb8-452e-a218-8d79e8425fc8)

Company: https://www.keypedia.com/companies/ducommun-labarge-technologies/9f552cb3-d285-4b49-a1ee-d9adbd6ba6d7

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
